Cochrane Clinical Answers
Cochrane Clinical Answers (CCAs) provide a readable, digestible, clinically focused entry point to rigorous research from Cochrane systematic reviews. They are designed to be actionable and to inform decision making at the point of care and have been added to relevant sections of the main Best Practice text.
- What are the benefits and harms of budesonide for induction of remission in Crohn's disease?
- How do the immunosuppressive drugs azathioprine and 6-mercaptopurine compare with placebo or infliximab for inducing remission in people with Crohn's disease?
- How does adalimumab compare with placebo for inducing remission in people with Crohn's disease?
- How does adalimumab compare with placebo for managing Crohn's disease in adults and adolescents?
- How does surveillance compare with no surveillance for detecting colon cancer in people with ulcerative colitis or inflammatory bowel disease?
Use of this content is subject to our disclaimer